IGC Pharma, Inc. — Director's Dealing 2017

Nov 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2017-10-18

Reporting Person: MUKUNDA RAM (Director, Exec. Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-18	Common stock	D	25000	$0.41	Disposed	767289	Indirect
2017-10-18	Common stock	D	25000	$0.40	Disposed	742289	Indirect
2017-10-18	Common stock	D	25000	$0.40	Disposed	717289	Indirect
2017-10-18	Common stock	D	25000	$0.41	Disposed	692289	Indirect
2017-10-25	Common stock	D	25000	$0.41	Disposed	667289	Indirect
2017-10-25	Common stock	D	11834	$0.41	Disposed	655455	Indirect
2017-11-01	Common stock	D	13166	$0.45	Disposed	642289	Indirect
2017-11-01	Common stock	D	25000	$0.45	Disposed	617289	Indirect
2017-11-02	Common stock	D	25000	$0.46	Disposed	592289	Indirect
2017-11-03	Common stock	D	100000	$0.51	Disposed	492289	Indirect

Footnotes

F1: Represents shares held directly by CEO's spouse